当前位置: 首页 > 期刊 > 《中西医结合心血管病》 > 20209
编号:13493830
替格瑞洛在急性冠脉综合征中应用的研究进展(2)
http://www.100md.com 2020年3月25日 《中西医结合心血管病电子杂志》 20209
     参考文献

    [1] Guerrero C,Garay A,Albert Ariza-Solé,et al. Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor:Insights from the RENAMI registry[J].Thrombosis Research,2018,167.

    [2] Bonaca M P,Storey R F,Theroux P,et al.Efficacy and Safety of Ticagrelor Over?Time in Patients With Prior MI in?PEGASUS-TIMI 54[J].Journal of the American College of Cardiology,2017,70(11):1368-1375.

    [3] Asher E,Frydman S,Katz M,et al.Chewing versus Swallowing Ticagrelor to Accelerate Platelet Inhibition in Acute Coronary Syndrome - the CHEERS study[J].Thrombosis and Haemostasis,2017,117(4):727-733.

    [4] Kilic S,Fabris E,Van'T A H,et al.Thrombus aspiration and prehospital ticagrelor administration in ST-elevation myocardial infarction:Findings from the ATLANTIC trial.[J].American Heart Journal,2018,196:1.

    [5] Du X,Zheng Y,Yang P,et al.YINGLONG:A Multicenter,Prospective,Non-Interventional Study Evaluating the Safety and Tolerability of Ticagrelor in Chinese Patients with Acute Coronary Syndrome[J].Advances in Therapy,2019,36(7):1595–1605.

    作者簡介:张岱曦(1993年-)男,汉族,河北省唐山市路北区,住院医师,研究生,研究方向:心血管内科。

    通讯作者:刘晓堃, http://www.100md.com(张岱曦 刘晓堃 姚家雪 卢芳 尚小童)
上一页1 2